| Literature DB >> 35247328 |
Andrew Chang1, Xinyu Xiang2, Jing Wang1, Carolyn Lee3, Tamta Arakhamia1, Marija Simjanoska1, Chi Wang4, Yari Carlomagno5, Guoan Zhang6, Shikhar Dhingra7, Manon Thierry8, Jolien Perneel9, Bavo Heeman9, Lauren M Forgrave10, Michael DeTure5, Mari L DeMarco10, Casey N Cook5, Rosa Rademakers9, Dennis W Dickson5, Leonard Petrucelli5, Michael H B Stowell11, Ian R A Mackenzie12, Anthony W P Fitzpatrick13.
Abstract
Misfolding and aggregation of disease-specific proteins, resulting in the formation of filamentous cellular inclusions, is a hallmark of neurodegenerative disease with characteristic filament structures, or conformers, defining each proteinopathy. Here we show that a previously unsolved amyloid fibril composed of a 135 amino acid C-terminal fragment of TMEM106B is a common finding in distinct human neurodegenerative diseases, including cases characterized by abnormal aggregation of TDP-43, tau, or α-synuclein protein. A combination of cryoelectron microscopy and mass spectrometry was used to solve the structures of TMEM106B fibrils at a resolution of 2.7 Å from postmortem human brain tissue afflicted with frontotemporal lobar degeneration with TDP-43 pathology (FTLD-TDP, n = 8), progressive supranuclear palsy (PSP, n = 2), or dementia with Lewy bodies (DLB, n = 1). The commonality of abundant amyloid fibrils composed of TMEM106B, a lysosomal/endosomal protein, to a broad range of debilitating human disorders indicates a shared fibrillization pathway that may initiate or accelerate neurodegeneration. Published by Elsevier Inc.Entities:
Keywords: DLB; FTLD-TDP; PSP; TMEM106B; amyloid fibrils; cryo-EM; endosome; lysosome; neurodegeneration; proteolysis
Mesh:
Substances:
Year: 2022 PMID: 35247328 PMCID: PMC9018563 DOI: 10.1016/j.cell.2022.02.026
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 66.850